معرفی
Maya Buch is a Clinical Professor of Rheumatology and Director of Experimental Medicine at the University of Manchester's Centre for Musculoskeletal Research. She holds leadership roles including NIHR Senior Investigator, Co-lead of the NIHR-BHF Cardio-Immune partnership, and National Lead for the NIHR Bioresource in systemic sclerosis. Her research focuses on precision medicine in rheumatoid arthritis, cardiovascular complications of immune diseases, and improving therapeutics for systemic sclerosis.
- NIHR Manchester Biomedical Research Centre: Leads the Advanced Diagnostics & Therapeutics Catalyst cluster
- Chief Investigator of the MRC-BHF UK CARDIO-IMID partnership
- Chair of the MRC-NIHR Efficacy, Mechanism, Evaluation Programme (2025–2027)
Research Themes: Precision medicine in RA (PRECISE-RA), cardiovascular pathology in IMIDs (CARDIO-IMID), and systemic sclerosis outcomes.
Key Projects: PHOSP-COVID consortium, BHF Centre for Research Excellence, and NIHR Versus Arthritis collaboration. Her work contributes to SDG3 (Good Health) and SDG10 (Reduced Inequalities).
Over 146 publications focus on rheumatology, cardiovascular comorbidity, and immunotherapies. Notable articles include studies on corticosteroid use in severe COVID-19 and biomarkers in refractory RA.
- Scientific Leadership: 3 active grants, including £multi-million initiatives
- Collaborations: Global networks in rheumatology and cardiovascular medicine
Labs/Teams: Leads experimental medicine teams at Manchester and collaborates with Leeds University as a Visiting Professor.
